Multiple voltage-gated K' channels contribute to the repolarization phases of the cardiac action potential and are targets of several antiarrhythmic drugs. The Kvl.5 K' channel gene is expressed in the heart, and heterologous expression of this gene generates a slowly inactivating K' current. Previously, we found that glucocorticoids specifically upregulate pituitary Kvl.5 gene expression. To test whether these steroids might also induce Kvl.5 gene expression in the heart, cardiac channel mRNA and protein were measured by RNase protection assay and by immunoblotting with antibody specific for the extracellular domain of Kvl.5 polypeptide. Kvl.5 mRNA and immunoreactive protein appeared to be more abundant in rat ventricle than atrium. Reduction of endogenous glucocorticoids by adrenalectomy decreased ventricular Kvl.5 mRNA :'8-fold, which was estimated by using cyclophilin mRNA as an internal control. Kvl.5 immunoreac-
M ultiple voltage-gated K' channels participate in the various repolarization phases of the cardiac action potential. Molecular biological studies have shown that at least seven distinct voltage-gated K' channel genes are expressed in rat cardiac tissues.1-3 These include four Shaker-related or Kvl subfamily genes: Kvl.1, Kv1.2, Kv1.4, and Kv1. 5.12 Studies with heterologous expression systems have revealed that Kvl.1, Kv1.2, and Kvl.5 genes encode slowly inactivating channels,2,45 whereas the Kvl.4 gene encodes a rapidly inactivating channel.467 Furthermore, these channel gene products can form heteromeric K' channels that exhibit current kinetics and pharmacological properties distinct from the original homomeric channels. [8] [9] [10] [11] [12] [13] For example, coexpression of Kvl. 4 and Kvl.5 in Xenopus oocytes generates heteromeric K' channels with intermediate inactivation kinetics. 14, 15 Hence, the diversity of voltage-gated K' currents in cardiac tissues may be due to expression of multiple gene products that assemble into a variety of homomeric and heteromeric channels.
The existence of multiple K' channel genes may also allow for differential control of channel expression. It is known that the expression of K' channel mRNAs varies between regions of rat heart: significant amounts of transcripts for Kvl.1, Kv1.2, Kv1.4, Kvl.5, and Kv2.1 are detected in the rat atrium, whereas only the last two channel mRNAs are abundant in the ventricle.' More-over, the expression of these mRNAs is differentially regulated during cardiac development: Kvl.5 mRNA expression is significant in neonatal and adult heart, whereas transcripts for the other four channel genes are nearly undetectable in prenatal heart and increase during heart development. 16 Finally, K' channel gene transcription may also be differentially regulated by extracellular signals, such as hormones and neurotransmitters. Previously, we have shown that glucocorticoid hormones specifically activate transcription of the Kvl.5 gene, leading to a rapid upregulation of Kvl.5 immunoreactive protein in GH3 clonal pituitary cells.1718 This upregulation of Kvl.5 gene expression also occurs in normal pituitary cells in vitro and in vivo. 19 Thus, K' channel gene expression is not static; it is cell typespecific and influenced by extracellular signals.
Our previous finding that dexamethasone directly activates Kvl.5 gene transcription in clonal pituitary cells18 raised the possibility that the glucocorticoid agonist may also upregulate the channel gene expression in other tissues. Kvl.5 mRNA is highly expressed in rat cardiac tissues1,2 and may encode a channel that is sensitive to several therapeutic drugs.20-24Therefore, we tested whether glucocorticoids might upregulate cardiac Kvl.5 gene expression in vivo by using adrenalectomized rats. In the present study, we report that dexamethasone specifically and markedly increases Kvl.5 mRNA and immunoreactive protein in the rat ventricle but not the atrium.
Materials and Methods Animals
Female Sprague-Dawley rats weighing 200 to 225 g (7 to 8 weeks old) were obtained from Zivic-Miller (Zelienople, Pa). For examining the effect of glucocorticoids, rats were either sham-operated or bilaterally adrenalectomized (Zivic-Miller) and kept in plastic cages with free access to food and drinking water. Adrenalectomized rats were given 0.9% NaCl as drinking water. Seven days after the operation, the rats were injected intraperitoneally with 10 mg dexamethasone in 0.5 mL sesame oil or with vehicle alone. Twenty-four hours after injection, the rats were anesthetized by inhalation of methoxyflurane and decapitated. The atria and ventricles were dissected and immediately frozen on dry ice.
Transfections
The full-length cDNAs encoding rat K' channels from Kv32 (Kvl.3), RK31 (Kvl.4), and Kv12 (Kvl.5) were subcloned into pRc/CMV (Invitrogen). Chinese hamster ovary (CHO) cells were transfected with one of these plasmid DNAs or with the parental plasmid pRc/CMV by the calcium phosphate precipitation method (Transfinity, BRL). Transfected cells were selected with 0.2 mg/mL neomycin. After three rounds of subclonings, cloned cells were tested for expression of K' channel mRNA by Northern blot hybridization18"19 and for K' currents by the standard whole-cell patch-clamp method.25
RNA Isolation and Measurements
Total RNAs were isolated from a part of the frozen tissues by a one-step method with acid phenol guanidium thiocy-anate26 with additional extractions. Briefly, the obtained RNA pellet was dissolved in solution D and extracted repeatedly with an equal volume of phenol-chloroform-isoamylalcohol (25:24:1) until an intermediate layer of proteins became invisible. RNA concentrations were determined spectrophotometrically by using absorbance at 260 nm (A260)=40 mg RNA.
For Northern blotting, an aliquot of total RNA was electrophoresed on 1% formaldehyde-agarose gel and transferred to nylon membrane by capillary action. Prehybridization and hybridizations were performed as described previously18,19 by using random priming-labeled rat cDNA probes: EcoRI-HindlIl fragment of Kv12 for Kv1.5, HindIII-BamHI fragment of drkl27 for Kv2.1, Pst I-BamHI fragment of p1B1528 for cyclophilin, Pst I-Pst I fragment of pGAPDH29 for glyceraldehyde phosphate dehydrogenase, and Pst I-Pst I fragment of pANF-13°for atrial natriuretic factor. Densitometric measurements of autoradiograms (LKB 2400 Gel ScanXL, version 1) was used to quantify hybridization signals.'8 K' channel mRNA levels were normalized by reprobing blots with cyclophilin cDNA probe. 19 For RNase protection assay, parts of rat Kvl.5 cDNA and cyclophilin cDNA were subcloned into pGEM1 (Promega). The 5'-end EcoRI-blunt-ended Bgl II fragment of rat Kvl.5 cDNA (pGEM-A-Kv1.52) corresponding to the sequence -295 to 4 was subcloned into the EcoRI-Sma I site of pGEM1 (pKvl EB300). The 5'-end Pst I-Asp 700 fragment of rat cyclophilin cDNA (plB15)28 corresponding to the sequence -6 to 104 was subcloned into the Pst I-Sma I site of pGEM1 (pCyc PA100). RNA probes were prepared from EcoRIdigested pKvl EB300 (the 5'-end Kvl.5 probe), HindlIldigested pCyc PA100 (internal control probe), or Xba I-digested pGEM-A-Kv1.52 (the 3'-end Kvl.5 probe)'8 by using either SP6 or T7 polymerase. Solution hybridization was performed with =5 x 10' cpm of one of the Kvl.5 probes and cyclophilin probe, as described previously.18 RNase digestion, recovery of protected RNAs, and running a denaturing gel were performed as described previously.'8 Kvl.5 mRNA levels were determined by densitometric measurements of autoradiograms (LKB 2400 Gel ScanXL, version 1) using cyclophilin mRNA levels as internal controls.
Antibody Production and Immunoblot Analysis
Polyclonal anti-Kvl.5 antisera were generated by immunization of rabbits (HTI Bio-Products, Ramona, Calif) with a fusion protein containing a part of the extracellular loop between S1 and S2 domains of rat Kvl.5 polypeptide2 (amino acids 272 to 312, K41E) and bacterial glutathione S-transferase (GST).
The frozen ventricles (=0.5 g) were thawed on ice and homogenized in 10 vol of a solution (0.25 mol/L sucrose, 1 mmol/L EDTA, 1 mmol/L phenylmethylsulfonyl fluoride, and 1 mmol/L iodoacetamide). Nuclear debris and undisrupted tissues were removed by centrifugation of the homogenate at lOOOg for 10 minutes. The low-speed supernatant was then centrifuged at 100 OOOg for 1 hour. The resulting pellet was washed with a solution containing (mmol/L) Tris-HCl 20 (pH 7.4), EDTA 1, phenylmethylsulfonyl fluoride 1, and iodoacetamide 1 and referred to as post-nuclear membrane fraction. Cultured cells were lysed in a hypotonic solution, and the lysed cells were centrifuged at 15 OOOg for 20 minutes. The postnuclear membrane fraction was then prepared by homogenization and differential centrifugation of the pelleted total membrane fraction, as described for the ventricular tissues. Protein concentrations were determined by using Bio-Rad protein assay solution with human immunoglobulin as a standard. The post-nuclear membrane proteins were separated on a 7.5% sodium dodecyl sulfate-polyacrylamide gel and transferred to nitrocellulose membrane. The nitrocellulose membrane was coated with 5% nonfat dry milk in phosphatebuffered saline containing 0.1% Tween 20. The coated membrane was probed with 1/2000 dilution of anti-K41E serum or 1/200 dilution of affinity-purified anti-K41C18 in the coating solution. Bound antibodies were detected with sheep anti-rabbit IgG conjugated with horseradish peroxidase and visualized with enhanced chemiluminescence reagents (ECL, Amersham). Kvl.5 immunoreactive proteins were measured by densitometry using enhanced laser scanning (LKB 2400 Gel ScanXL, version 1), as described previously.'8
Results

Kvl.5 K' Channel Expression in Rat Heart
It has been shown that Kvl.5 mRNA is significant in both rat atrium and ventricle by Northern blot analysis.' To obtain more quantitative information about cardiac Kvl.5 mRNA expression, we used RNase protection assays with the two distinct regions of the rat Kvl.5 cDNA as probes ( Fig 1) . Various amounts of total RNAs isolated from young (7to 8-week-old) adult female atria and ventricles were used to compare the abundance of Kvl.5 mRNA in these two tissues. The two probes detected significant signals of Kvl.5 mRNA in both the atrium and ventricle (Fig 1) . Densitometric measurements of the signals indicate that the two probes gave consistent results, suggesting that no alternatively spliced transcripts for Kvl.5 mRNA are present in the rat heart. The steady state concentration of Kvl.5 mRNA measured in two independent experiments was estimated to be~18-fold higher in the ventricle than in the atrium. Therefore, Kvl.5 mRNA expression varies between the atrium and ventricle.
To examine cardiac Kvl.5 protein expression, we generated a polyclonal antibody specific for the Kvl.5 polypeptide (anti-K41E). This antibody was produced against a fusion protein containing a portion of the extracellular loop between S1 and S2 transmembrane domains of the Kvl.5 polypeptide corresponding to amino acids 272 to 312,2 which is unique for Kvl.5 channel (Fig 2A) . The specificity of the antibody was tested by immunoblot analysis with the post-nuclear membrane fractions prepared from CHO cells stably transfected with one of three rat Shaker-related K' channel genes (Kvl.3, Kv1.4, and Kvl.5; Fig 2B) . These transfected cells express significant amounts of the RNase digestion, the protected RNAs were isolated and separated on a 4% polyacrylamide gel containing 7.8 mol/L urea. Undigested RNA probes were also applied to the gel (probe).
The gels were dried and exposed to an X-ray film for various times to quantify the signals. The probes consist of the sequences corresponding to channel cDNA and a part of the vector: the 3'-end Kvl.5 probe, 445 (424+21) bases; the 5'-end Kvl.5 probe, 357 (299+58) bases; and the cyclophilin probe, 166 (111+55) bases. The lengths of the protected fragments were consistent with the cDNAs inserted in the vector. Smaller fragments seen in the figure were mostly due to shorter (not fully extended) RNA probes. Kvl.5 mRNA in the ventricle was estimated to be 1 8-fold more abundant than that in the atrium (the average of the two independent experiments with the two different probes).
corresponding K' channel mRNA as well as voltagegated outward K' currents (50 to 500 pA/pF at +50-mV test potential; data not shown). The antibody shows a strong reaction with an --76-kD protein present only in Kvl.5 -transfected cells but not in mock-transfected or Kv1.3or Kvl.4-transfected cells ( Fig 2B) . Preadsorption of the antiserum with 50 gg of the fusion protein (GST-K41E) but not with the parental protein (GST) abolished this reaction with the 76-kD protein (data not shown). This antibody also exhibits strong binding to a 76-kD membrane protein from many rat tissues, including the skeletal muscle, atrium, ventricle, and brain, as well as from GH3 clonal pituitary cells ( Fig 2B) . The antibody against a part of the C-terminus of Kvl.5 polypeptide (anti-K41C)18 reacts with the identical size of the membrane protein in the Kvl.5-transfected cells and various tissues (data not shown). Thus, the antibody against the extracellular domain (anti-K41E) specifically recognizes Kvl.5 K' channel protein.
To compare the abundance of Kvl.5 immunoreactive protein in the atrium and ventricle, two different amounts of the post-nuclear membrane proteins from the two tissues were subjected to immunoblot analysis with the anti-K41E antibody ( Fig 2C) . Densitometric measurements of the 76-kD Kvl.5 immunoreactive protein indicate that this protein is approximately eightfold more abundant in the ventricle than the atrium from two independent experiments. Thus, the expression of Kvl.5 immunoreactive protein also varies between the two regions of rat heart. Glucocorticoid Induction of Kvl.5 mRNA Expression Three groups of animals were used for experiments: sham-operated and vehicle-injected (sham), bilaterally adrenalectomized and vehicle-injected (Adex), and bilaterally adrenalectomized and dexamethasone-injected (Adex+Dex). Seven days after the operation, the rats were injected with either 10 mg dexamethasone or vehicle alone. Twenty-four hours after injection, the rats were killed. First we measured steady state levels of voltage-gated K' channel mRNAs in whole hearts of these animals by Northern blot analysis (n=3 for each Fig 3) . Kvl.5 probe exhibits a single band of =3.5 kb on a Northern blot, whereas Kvl.4 and Kv2.1 probes detect multiple bands ( Fig 3A) . The 3.5-kb Kvl.5 mRNA was significantly decreased by adrenalectomy (Adex versus sham, P<.05 by two-tailed Bonferroni test) and increased by injection of dexamethasone into the adrenalectomized rats (Adex+Dex versus Adex, P<.01; Fig 3B) . In contrast, the larger sizes of mRNAs detected by the latter two probes (=14 kb for Kvl.4 and "12 kb for Kv2.1; Fig 3B) as well as the smaller ones (=4.5 kb for Kvl.4 and 4 kb for Kv2.1; data not shown) were unaffected. Hence, glucocorticoids specifically induce the expression of Kvl.5 mRNA without affecting Kvl.4 and Kv2.1 mRNA levels in rat heart. To test whether this regulation of Kvl.5 mRNA expression might occur in both the ventricle and atrium, total RNAs were isolated from the ventricles and atria of another set of animals, and RNase protection assays were performed (n-4 for each group; Fig 4) . In the ventricle, reduction of endogenous glucocorticoids by adrenalectomy decreased the steady state level of Kvl.5 mRNA =8-fold, estimated by using cyclophilin mRNA levels as internal controls (Adex versus sham, P<.01 by two-tailed Bonferroni test; Fig 4A and 4C) . Furthermore, injection of dexamethasone in the adrenalectomized rats caused an increase in ventricular Kvl.5 mRNA level '50-fold within 24 hours (Adex+Dex versus Adex, P<.01). Since ventricular cyclophilin mRNA expression might be affected by these operations, we compared cyclophilin mRNA levels with glyceraldehyde phosphate dehydrogenase (GAPDH) mRNA expression, another constitutively expressed gene, by Northern blot analysis. The results indicate that the expression of cyclophilin mRNA is =30% higher in the Adex group than in the sham and Adex+Dex groups on the basis of GAPDH mRNA levels (data not shown). Thus, with GAPDH mRNA expression assumed to be constant, Kvl.5 mRNA levels as decreased by '-6-fold by adrenalectomy and increased by :38-fold by injection of dexamethasone.
Although the expression of whole-heart Kvl.4 and Kv2.1 mRNA levels was unchanged, these channel mRNA levels might be regulated only in the ventricle. To test this possibility, we attempted to measure ventricular Kvl.4 and Kv2.1 mRNA levels. We found that ventricular Kv2.1 mRNA expression was unaffected by either adrenalectomy or injection of dexamethasone ( Fig 5) and that Kvl.4 mRNA was nearly undetectable in the ventricle from all three groups of animals (data not shown). Thus, Kvl.5 mRNA expression in the ventricle is specifically and dramatically upregulated by glucocorticoids.
In contrast to the dramatic changes in ventricular Kvl.5 mRNA expression, neither adrenalectomy nor dexamethasone injection significantly affected atrial channel mRNA expression ( Fig 4B and 4C) . This failure of the glucocorticoid agonist to regulate atrial Kvl.5 mRNA expression is not due to a lack of the functional steroid receptors, since an upregulation of atrial natriuretic factor (ANF) mRNA expression31-35 was seen in the same RNA samples (data not shown). ANF mRNA was decreased by '~30% by adrenalectomy (Adex compared with sham) and increased ='2.2-fold by the subsequent injection of dexamethasone (Adex+Dex com- Fig 3) , with each group consisting of four animals. RNase protection assays were performed with 5 gg total RNA with the 3'-end Kvl.5 probe. The gels were dried and exposed to X-ray films at -80C for various times. Exposure times for the ventricular Kvl.5 mRNA, atrial Kvl.5 mRNA, and cyclophilin mRNA were 8 hours, 2 days, and 15 minutes, respectively. C, Bar graph showing Kvl.5 mRNA levels determined by measuring the signals by densitometry and normalized by using cyclophilin mRNA levels as internal controls. Columns represent Kvl.5 mRNA levels relative to the means of the sham group with error bars indicating SEM (n=4). Note that Kvl.5 mRNA level in the sham group is~= 18-fold higher in the ventricle than the atrium. Ventricular Kvl.5 mRNA level in the Adex group is significantly lower than that in the sham group (P<.01 by two-tailed Bonferroni test), and that in the Adex+Dex group is significantly higher than that in the Adex group (P<.01).
pared with Adex) with the GAPDH mRNA level used as a control. Hence, glucocorticoids specifically upregulate Kvl.5 mRNA expression in the ventricle but not the atrium. protein, Kvl.5 immunoreactivity was measured by using antibody specific for the extracellular loop of Kvl.5 polypeptide (anti-K41E). Post-nuclear membrane fractions were prepared by homogenization and differential centrifugation of the ventricles (the same tissues used for channel mRNA measurement in Fig 4, n=4 for each group). The membrane proteins were then subjected to immunoblot analysis (Fig 6A and 6B) . Densitometric measurements of the 76-kD Kvl.5 immunoreactive protein revealed that this protein decreased -6-fold by adrenalectomy (Adex versus sham, P<.05 by twotailed Bonferroni test). Moreover, dexamethasone injection into the adrenalectomized rats increased the Kvl.5 immunoreactive protein m20-fold (Adex+Dex versus Adex, P<.01). Qualitatively similar results were also seen when Kvl.5 immunoreactivity was measured from whole heart (n=3 for each group). Therefore, glucocorticoids act within a day to dramatically increase the expression of Kvl.5 immunoreactive protein in rat ventricle.
Discussion Many hormones and neurotransmitters produce acute effects on excitability by modulating the gating of ion channels already present in the plasma membrane. In addition, these extracellular stimuli may cause longterm changes in excitability by regulating the expression of ion channels. It has been shown that treatment of primary cultured neonatal cardiac myocytes with high KCl, Bay K 8644, or phorbol ester increases Kvl.4 mRNA expression.36 Furthermore, significant changes in Kvl.4 and Kvl.5 mRNA levels are seen in hypertro- phied ventricles produced for months by reversal of renovascular hypertension. 36 The present results demonstrate that the glucocorticoid agonist dexamethasone specifically upregulates the expression of Kvl.5 K' channel mRNA in rat ventricle in vivo within a day. Moreover, we showed that this upregulation of the cardiac K' channel mRNA expression is associated with a dramatic increase in K' channel immunoreactive protein. Thus, regulation of K' channel gene expression may constitute a novel mechanism underlying long-term control of cardiac excitability. Glucocorticoid hormones are known to produce biological effects by inducing gene transcription via a soluble receptor protein. We have previously found that inhibition of protein synthesis does not abolish dexamethasone-induced Kvl.5 gene transcription in GH3 clonal pituitary cells.'8 This suggests that the glucocorticoid-receptor complex directly acts on the regulatory region of the Kvl.5 gene to activate its transcription. This is also supported by a recent study showing the presence of a putative glucocorticoid-responsive element in the 5' flanking region of the rat Kvl.5 gene. 37 Therefore, any cells that express both Kvl.5 gene and the glucocorticoid receptor might be expected to respond to dexamethasone to induce transcription of the channel gene. However, despite the fact that the glucocorticoid receptor is present in both atrial and ventricular myocytes,38 the glucocorticoid agonist upregulated Kvl.5 mRNA expression in the ventricle but not the atrium. This finding could not be due to a defect in atrial myocyte glucocorticoid action in our experiments, because we verified that ANF mRNA expression was increased by dexamethasone in the same samples. Hence, glucocorticoid induction of Kvl.5 mRNA expression differs between the atrium and ventricle. A similar differential hormone effect in the two regions of the heart is seen with thyroid hormone induction of myosin heavy chain expression: thyroid hormones markedly upregulate the expression of a-and /-myosin heavy chains in the ventricle but not the atrium. 39 In addition to the heart, we also found that dexamethasone markedly increases the channel mRNA expression in the pituitary'9 and skeletal muscle (K. Takimoto, unpublished data), whereas only a small change is seen in the hypothalamus and the lung (K. Takimoto and B.R. Pitt, unpublished data). Moreover, the changes in ventricular Kvl.5 mRNA produced by adrenalectomy or injection of dexamethasone are larger than those in the pituitary'9 and skeletal muscle. Therefore, the glucocorticoid agonist might also indirectly affect Kvl.5 gene expression in the ventricle, in addition to directly inducing channel gene transcription. These findings suggest that the hormone induction of Kvl.5 gene might require an additional factor whose expression is confined in certain tissues. Alternatively, some tissues might possess a factor that represses hormone responsiveness. In any case, our findings demonstrate that glucocorticoids differentially regulate atrial and ventricular K' channel gene expression.
Previous studies from several laboratories have shown that voltage-gated K' channel mRNA expression is regionally and developmentally regulated in rat heart. However, there are some disagreements concerning the expression of Kvl.5 mRNA: one group reported that the expression of Kvl.5 mRNA is dramatically regulated in the ventricle during development and aging,5,36 whereas the other group showed relatively constant levels of Kvl.5 mRNA throughout early development.'6 Furthermore, the results from the two groups also differ concerning the levels of ventricular Kvl.4 mRNA: one group detected substantial amounts of Kvl.4 mRNA in the ventricle,36 whereas the other showed a nearly undetectable level of channel message.' Our results indicate that Kvl.5 mRNA and immunoreactive protein are much more abundant in the ventricle than the atrium of young (7to 8-week-old) adult rats. We also found that Kvl.4 mRNA is abundant in the atrium but not the ventricle. These discrepancies might be due to different experimental conditions that may influence channel mRNA levels. Indeed, recent findings'8,'93637 as well as findings in the present study suggest that expression of K' channel mRNAs is not static but is dynamically regulated under various conditions. For example, in adrenalectomized animals, Kvl.5 mRNA levels were comparable in the atrium and ventricle. Moreover, the regulation of channel mRNA expression might be regionally confined, as our results suggest. Further studies including detailed immunohistochemis-try and in situ hybridization are needed to resolve these issues.
Expression of the Kvl.5 gene in Xenopus oocytes generates a very slowly inactivating outward K' current. 25 Since rat and human atrial myocytes exhibit a prominent delayed rectifying outward K' current, Kvl.5 has been proposed to constitute the atrial delayed rectifier.5,6,14 However, our results demonstrate that Kvl.5 mRNA and immunoreactive protein are more abundant in rat ventricle than atrium. Thus, Kvl.5 protein is likely to contribute to the ventricular voltagegated outward K' current. There are two main components of ventricular voltage-gated K' current in the rat40: a tetraethylammonium (TEA)-sensitive delayed rectifier and a TEA-insensitive and 4-aminopyridinesensitive transient current. The fact that the heterologously expressed Kvl.5 channels differ from these native ventricular currents may be due to the association of Kvl.5 channel subunit with other proteins. Such proteins might be other Shaker subfamily K' channel subunits. For example, Kvl.4 encodes a channel that rapidly inactivates in heterologous expression systems.46,7 Therefore, Kvl.5 protein might be present in an association with Kvl.4 protein to form the transient K' current in rat ventricle. However, a previous study1 and our results indicate that transcripts for this gene are nearly undetectable in rat ventricle. Another possibility is suggested by the recent findings that brain dendrotoxin-binding voltage-gated K' channels are associated with auxiliary ,B subunits41 and that the association of certain P3 subunits affects inactivation kinetics. 42 Thus, it is possible that the ventricular Kvl.5 channel may encode the transient K+ current by associating with a P3 subunit. Resolving this issue will require purification and biochemical identification of cardiac K' channels.
The dramatic upregulation of Kvl.5 immunoreactive protein in rat ventricle may produce many physiological and pharmacological effects. We have previously found that the dexamethasone-induced upregulation of Kvl.5 immunoreactive protein is associated with an increase in voltage-gated K' current density in GH3 cells. 18 Thus, the upregulation of ventricular Kvl.5 immunoreactive protein might also lead to an increase in the number of functional K' channels. In patients with long QT syndrome, congestive heart failure,43 or chronically infarcted regions of the ventricle,44 action potential repolarization mechanisms are compromised. Glucocorticoid induction of Kvl.5 channel expression might be a novel therapeutic treatment to compensate for the loss of normal repolarization mechanisms. In addition to influencing basal electrical activity, hormone regulation of Kvl.5 gene expression might also affect responsiveness to hormones, autonomic inputs, and clinically useful drugs. For example, a1-adrenergic agonists suppress the delayed rectifying K+ current in rat ventricular myocytes.45 Likewise, several clinically useful drugs, especially class III antiarrhythmic drugs, act on voltage-gated K+ channels to produce their therapeutic effects. Heterologously expressed Kvl.5 K+ channels are found to be sensitive to quinidine,20 verapamil,21 clofilium,22 tedisamil,23 and an antihistamine.24 Hence, regulation of K' channel expression may influence basal electrical activity, its modulation by natural extracellular signals, and the efficacy of therapeutic drugs.
